Latest Industry Insights

In this article, we explore how AI, robotics and advanced software are transforming biopharma labs, the challenges of adopting these technologies and the vision for the “Lab of the Future.”

In this interview, Dr. Denise Teber, a scientific expert in molecular biology at Charles River Laboratories, discusses how ddPCR is being used to improve contamination risk management.

In this interview, Dr. Eleonora Juarez explains how Oxford Nanopore’s new Hereditary Cancer Panel could streamline testing, expand access and influence future best practices in hereditary cancer workflows.

In this interview, Dr. Freya Leech, a researcher at NanoFCM, discusses the current challenges and future prospects in nanoparticle drug delivery.

Explore how onshoring pharmaceutical manufacturing could reshape US drug production and boost supply chain resilience.

In this interview, Technology Networks spoke with Gene Mack, chief executive officer and president of Gain Therapeutics, to find out more about the company’s mission, its science and its vision for the future of neuroscience drug development.

In this interview, Felix Spira, senior manager at Molecular Devices, discusses how automation and AI improve brain organoid cultivation, enabling consistent long-term models that advance research into complex neurodegenerative diseases.

In the heart of Cambridge, a quiet revolution is reshaping the way science startups scale: one built not only on breakthrough molecules and patents, but also on collaborative spaces, shared values and pragmatic support.

Are GLP-1 weight loss drugs the best we can do? Learn why some are pursuing alternatives to appetite suppression.

Dr. Maria Anastasiadi explains how her team is pioneering new methods to combat honey adulteration.